X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bacterial proteins - antagonists & inhibitors (4) 4
index medicus (4) 4
l-lysine 6-transaminase - antagonists & inhibitors (4) 4
bacterial proteins - metabolism (3) 3
l-lysine 6-transaminase - metabolism (3) 3
latent tuberculosis - drug therapy (3) 3
mycobacterium tuberculosis (3) 3
mycobacterium tuberculosis - enzymology (3) 3
tuberculosis (3) 3
analysis (2) 2
antitubercular agents - chemistry (2) 2
antitubercular agents - therapeutic use (2) 2
crystals (2) 2
enzyme inhibitors - chemistry (2) 2
enzyme inhibitors - pharmacology (2) 2
humans (2) 2
l-lysine 6-transaminase (2) 2
latent tuberculosis - diagnosis (2) 2
lysine (2) 2
molecular docking simulation (2) 2
structure (2) 2
transaminases - metabolism (2) 2
2-aminomethyl piperidine derivative (1) 1
alanine - metabolism (1) 1
allysine ethylene acetal (1) 1
amino acid oxidoreductases - chemistry (1) 1
amino acid oxidoreductases - metabolism (1) 1
amino acid substitution (1) 1
angiotensin-converting enzyme (1) 1
animals (1) 1
antihypertensive agents - chemical synthesis (1) 1
antihypertensive agents - chemistry (1) 1
antihypertensive agents - metabolism (1) 1
antimicrobial peptides (1) 1
antimycobacterial (1) 1
antitubercular agents - chemical synthesis (1) 1
antitubercular agents - pharmacology (1) 1
bacterial proteins - chemistry (1) 1
bacterial proteins - genetics (1) 1
binding sites (1) 1
biomarkers (1) 1
biomarkers - analysis (1) 1
bioreactors (1) 1
carboxylic acids - pharmacology (1) 1
catalytic domain (1) 1
catalytic domain - genetics (1) 1
chemical phenomena (1) 1
chemical properties (1) 1
chemistry (1) 1
chemistry, medicinal (1) 1
chiral intermediates (1) 1
chlorides - pharmacology (1) 1
crystal structure (1) 1
crystallography, x-ray (1) 1
d-amino-acid oxidase - chemistry (1) 1
d-amino-acid oxidase - metabolism (1) 1
diagnosis (1) 1
disease models, animal (1) 1
dna topoisomerases, type i - chemistry (1) 1
dna topoisomerases, type i - metabolism (1) 1
dose-response relationship, drug (1) 1
drug candidate (1) 1
drug design (1) 1
drug discovery - methods (1) 1
enzymatic synthesis (1) 1
enzyme inhibitors - chemical synthesis (1) 1
enzyme inhibitors - therapeutic use (1) 1
enzymes - chemistry (1) 1
enzymes - pharmacology (1) 1
escherichia coli - genetics (1) 1
escherichia coli - metabolism (1) 1
fermentation (1) 1
formate dehydrogenase (1) 1
formates - pharmacology (1) 1
gene-expression (1) 1
genetic aspects (1) 1
genetics & heredity (1) 1
glu243 switch (1) 1
glutamate dehydrogenase - chemistry (1) 1
glutamate dehydrogenase - metabolism (1) 1
halogens - pharmacology (1) 1
hydrogen bonding (1) 1
in-vivo activities (1) 1
infectious disease (1) 1
inhibition (1) 1
inhibitory concentration 50 (1) 1
isocitrate lyase (1) 1
isocitrate lyase - antagonists & inhibitors (1) 1
isocitrate lyase - metabolism (1) 1
isocitrate lyase-1 (1) 1
ketoglutaric acids - metabolism (1) 1
kinetics (1) 1
l-lysine (1) 1
l-lysine 6-transaminase - chemistry (1) 1
l-lysine 6-transaminase - genetics (1) 1
latent tuberculosis (1) 1
latent tuberculosis - microbiology (1) 1
latent tuberculosis infection (1) 1
lysine - metabolism (1) 1
lysine 3-aminotransferase (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Tuberculosis, ISSN 1472-9792, 2015, Volume 95, Issue 6, pp. 786 - 794
Summary Mycobacterium tuberculosis (MTB) has remarkable ability to persist in the human host and causes latent infection in one third of the world population.... 
Infectious Disease | Pulmonary/Respiratory | Latent tuberculosis | Lysine ɛ-aminotransferase | Mycobacterium tuberculosis | Zebra fish M. marinum model | Zebra fish M. marinum model | Lysine É-aminotransferase | Antitubercular Agents - chemical synthesis | Humans | Drug Discovery - methods | Structure-Activity Relationship | Enzyme Inhibitors - chemical synthesis | Molecular Targeted Therapy | Mycobacterium tuberculosis - drug effects | L-Lysine 6-Transaminase - antagonists & inhibitors | Latent Tuberculosis - diagnosis | Dose-Response Relationship, Drug | Latent Tuberculosis - drug therapy | Time Factors | Mycobacterium Infections, Nontuberculous - microbiology | L-Lysine 6-Transaminase - metabolism | Molecular Structure | Disease Models, Animal | Mycobacterium marinum - drug effects | Bacterial Proteins - antagonists & inhibitors | Microbial Viability - drug effects | Antitubercular Agents - pharmacology | Enzyme Inhibitors - pharmacology | Mycobacterium marinum - enzymology | Zebrafish | Animals | Mycobacterium tuberculosis - enzymology | Bacterial Proteins - metabolism | Molecular Docking Simulation | Latent Tuberculosis - microbiology | Mycobacterium Infections, Nontuberculous - drug therapy | Mycobacterium tuberculosis - growth & development | Lysine | Analysis | Tuberculosis | Structure | Crystals | Medical research | Medicine, Experimental
Journal Article
Journal of Biochemistry, ISSN 0021-924X, 1984, Volume 95, Issue 2, pp. 559 - 565
L-Lysine:2-oxoglutarate 6-aminotransferase catalyzes very slow transamination between L-alanine and 2-oxoglutarate. A high concentration of anions such as... 
Chlorides - pharmacology | Phenylglyoxal - pharmacology | Transaminases - antagonists & inhibitors | Alanine - metabolism | L-Lysine 6-Transaminase | Chemistry | Halogens - pharmacology | Formates - pharmacology | Chemical Phenomena | Transaminases - metabolism | Lysine - metabolism | Kinetics | Carboxylic Acids - pharmacology
Journal Article
Book Review
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.